Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Interest Income | 47,701 | 48,166 | 50,237 | 49,692 | 49,634 |
| Interest Expense | 24,333 | 24,777 | 26,516 | 29,087 | 29,364 |
| Interest Income (Net of Interest Expense) | 23,368 | 23,389 | 23,721 | 20,605 | 20,270 |
| Non-Interest Income | 6,745 | 5,829 | 6,448 | 5,742 | 4,569 |
| Sales | 30,113 | 29,218 | 30,169 | 26,347 | 24,839 |
| Credit Losses Provision | 2,227 | 2,086 | 3,600 | 1,525 | 1,475 |
| Non Interest Expenses | 19,752 | 19,667 | 19,375 | 18,757 | 17,557 |
| Pre-tax Income | 8,134 | 7,465 | 7,194 | 6,065 | 5,807 |
| Income Tax | 2,398 | 1,884 | 2,461 | 1,994 | 2,008 |
| Other Income | 32,467 | 32,242 | 33,710 | 35,152 | 35,171 |
| Net Income | $5,736 | $5,581 | $4,733 | $4,071 | $3,799 |
| EPS Basic Continuous Ops | 17.55 | 17.42 | 16.13 | 12.39 | 12.76 |
| EPS Basic Total Ops | 17.54 | 17.54 | 16.46 | 12.32 | 12.69 |
| EPS Diluted Continuous Ops | 16.98 | 16.63 | 15.64 | 12.12 | 12.53 |
| EPS Diluted Total Ops | 17.15 | 16.75 | 15.62 | 11.96 | 12.69 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $N/A |